The Effects of Prenatal Cannabis Exposure on the Basolateral Amygdala
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Abstract
Clinical and preclinical studies indicate prenatal cannabis exposure (PCE) pathologically affects fetal brain
development and may increase vulnerability to neuropsychiatric disorders, including schizophrenia and mood/anxiety
disorders. In review research from our lab suggests that fetal exposure to Δ9-THC sex-selectively impairs
mesocorticolimbic (MCL) circuit function. However, there is a distinct lack of focus on PCE models on the BLA. The
BLA plays a central role within the MCL where it directly interacts with the VTA, PFC and HIPP. Importantly, our
model exhibits significant VTA hyperdopaminergic activity, and sex-specific alterations to PFC/HIPP glutamate firing,
alongside region- and sex-specific changes in dopamine (DA), glutamate/GABA molecular markers. These result in
outward pathological behavioural manifestations with males exhibiting enhanced anxiety and both sexes exhibiting
cognitive deficits. Given the role of the BLA, it is necessary to mechanistically explore the effect of PCE on the BLA.
The present study characterized the interconnected pathophenotype of the BLA-MCL circuit using behavioural,
electrophysiological, molecular, and mechanistic assays.
Pregnant Wistar rats were assigned to VEH (n=10 dams; n=4 progeny/sex/dam) or 3mg/kg THC (daily, i.p.; n=10
dams; n=4 progeny/sex/dam) from gestational day (GD) 7 to GD22. A subset of progeny (n=8/treatment/sex) were
sacrificed on PD21 for molecular assays of the NAc and BLA. Between PD70-85, a subset of progeny
(n=20/treatment/sex) were assessed for anxiety, depression, prepulse inhibition, and contextual fear. Between PD90120, in vivo electrophysiology was used to assess VTA DA-ergic neurons, glutamate, and GABA neurons in the
posterior/anterior BLA, and NAc GABA neurons. On PD120, remaining offspring were sacrificed and NAc and BLA
punchouts were obtained for molecular assays. A behaviour naïve subset (n=10/sex/treatment) received intra-BLA
cannulations for mechanistic assays between PD90-120.
In line with previous results, males exhibit a significant anxiogenic phenotype; however, males also exhibited
significantly less freezing, suggesting a deficit in contextual fear learning, consistent with significant increases in
GAD67 expression; males also exhibit increases in D1R and GABAARα1. Female progeny did not exhibit any
outward pathology but did exhibit significantly greater expression of vGLUT2, GABAARα1, and GABAARɣ2.
Disturbances in dopaminergic, glutamatergic, and GABAergic electrophysiological activity were also observed in the
male progeny within the VTA-BLA-NAc circuit, but not in the female progeny. These suggest that the anxiogenic
deficits observed in males are likely contingent on BLA disruptions, while the female progeny is protected from BLAdependant etiology. Mechanistic assays are currently ongoing.
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